![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1996-3181|10|2|163-174
ISSN: 1871-5273
Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.10, Iss.2, 2011-03, pp. : 163-174
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Disease-Modifying Therapies in Alzheimer's Disease: How Far Have We Come?
By Hüll Michael Berger Mathias
Drugs, Vol. 66, Iss. 16, 2006-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Do Cholinesterase Inhibitors Have Disease-Modifying Effects in Alzheimer's Disease?
By Giacobini E.
CNS Drugs, Vol. 15, Iss. 2, 2001-01 ,pp. :